Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4053506 | 1.00 | CA1 (0.42) | CA1CA9 | |
| SCHEMBL4053501 | 1.00 | CA1 (0.42) | CA1CA9 | |
| SCHEMBL1387069 | 1.00 | CA1 (0.42) | CA1CA9 | |
| SCHEMBL8167473 | 0.94 | CA1 (0.42) | CA1CA9 | |
| SCHEMBL2034105 | 0.94 | CA1 (0.36) | CA1CA9 | |
| SCHEMBL13618804 | 0.94 | CA1 (0.42) | CA1CA9 | |
| SCHEMBL12806281 | 0.92 | CA1 (0.38) | CA1CA9 | |
| SCHEMBL3294701 | 0.89 | ALDH1A1 (0.32) | CA1CA9 | |
| SCHEMBL2668138 | 0.86 | — | — | |
| SCHEMBL12796573 | 0.82 | CA1 (0.50) | CA1CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8383834-B2 | Process for preparing unsaturated lactones | SYMRISE AG (DE) | 2013-02-26 | — | — | US | disclosed |
| US-20090306411-A1 | PROCESS FOR PREPARING UNSATURATED LACTONES | SYMRISE GMBH & CO. KG (DE) | 2009-12-10 | — | — | US | disclosed |
| EP-1747211-B1 | PROCESS FOR PREPARING UNSATURATED LACTONES | SYMRISE GMBH & CO KG (DE) | 2009-08-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090306411-A1 | PROCESS FOR PREPARING UNSATURATED LACTONES | ALOX5, ALOX12, ALOX15 | CA1 535/4885CA9 2439/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.